tiprankstipranks
Advertisement
Advertisement

CGON Stock Latest News

Big Insider Buying Puts These 2 Stocks on the Radar
Market NewsBig Insider Buying Puts These 2 Stocks on the Radar
7d ago
ADBE
CGON
CG Oncology 1.15M share Block Trade priced at $66.87
PremiumThe Fly
CG Oncology 1.15M share Block Trade priced at $66.87
16d ago
CGON
Closing Bell Movers: Micron soars 14% after beat and raise
PremiumThe Fly
Closing Bell Movers: Micron soars 14% after beat and raise
17d ago
MU
ARM
CG Oncology 1.15M share Block Trade; price range $66.87-$67.87
PremiumThe Fly
CG Oncology 1.15M share Block Trade; price range $66.87-$67.87
17d ago
CGON
CG Oncology Shareholders Back Directors and Governance Proposals
PremiumCompany Announcements
CG Oncology Shareholders Back Directors and Governance Proposals
1M ago
8K
CGON
Oncolytics promotes John McAdory to COO
PremiumThe FlyOncolytics promotes John McAdory to COO
1M ago
CGON
ONCY
Alec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track
Premium
Ratings
Alec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track
2M ago
CGON
CG Oncology announces departure of president, COO Ambaw Bellete
Premium
The Fly
CG Oncology announces departure of president, COO Ambaw Bellete
2M ago
CGON
Wolfe sees CG Oncology COO exit as operational, no impact to key programs
PremiumThe Fly
Wolfe sees CG Oncology COO exit as operational, no impact to key programs
2M ago
CGON
CG Oncology Reshapes Executive Team Amid Leadership Transition
PremiumCompany Announcements
CG Oncology Reshapes Executive Team Amid Leadership Transition
2M ago
8K
CGON
CG Oncology initiated with a Peer Perform at Wolfe Research
PremiumThe Fly
CG Oncology initiated with a Peer Perform at Wolfe Research
2M ago
CGON
Buy Rating Reiterated on Robust Cretostimogene Data and De-Risked Phase 2 Program; $100 Price Target Maintained
PremiumRatings
Buy Rating Reiterated on Robust Cretostimogene Data and De-Risked Phase 2 Program; $100 Price Target Maintained
2M ago
CGON
CG Oncology reports first results from CORE-008 Cohort CX
PremiumThe FlyCG Oncology reports first results from CORE-008 Cohort CX
2M ago
CGON
CG Oncology price target raised to $82 from $77 at Truist
Premium
The Fly
CG Oncology price target raised to $82 from $77 at Truist
2M ago
CGON
CG Oncology price target raised to $81 from $79 at RBC Capital
Premium
The Fly
CG Oncology price target raised to $81 from $79 at RBC Capital
2M ago
CGON
CG Oncology price target raised to $80 from $77 at Wedbush
PremiumThe Fly
CG Oncology price target raised to $80 from $77 at Wedbush
2M ago
CGON
CG Oncology price target raised to $96 from $91 at JPMorgan
PremiumThe Fly
CG Oncology price target raised to $96 from $91 at JPMorgan
2M ago
CGON
CG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto
PremiumRatings
CG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto
2M ago
CGON
CG Oncology price target lowered to $83 from $84 at BofA
PremiumThe Fly
CG Oncology price target lowered to $83 from $84 at BofA
2M ago
CGON
Analyst Reiterates Buy on CG Oncology, Maintains $90 Price Target Ahead of Key Cretostimogene Data Readouts
PremiumRatingsAnalyst Reiterates Buy on CG Oncology, Maintains $90 Price Target Ahead of Key Cretostimogene Data Readouts
2M ago
CGON
Alec Stranahan Reiterates Buy on CG Oncology, Maintains $83 Price Target on Cretostimogene’s Best-in-Class Potential and Upcoming PIVOT-006 Catalyst
Premium
Ratings
Alec Stranahan Reiterates Buy on CG Oncology, Maintains $83 Price Target on Cretostimogene’s Best-in-Class Potential and Upcoming PIVOT-006 Catalyst
2M ago
CGON
CG Oncology reports Q1 EPS (71c), consensus (54c)
Premium
The Fly
CG Oncology reports Q1 EPS (71c), consensus (54c)
2M ago
CGON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >